Medicinal Product Regulation and Product Liability in South Africa
Medicinal product regulation and product liability in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie
A Q&A guide to medicinal product regulation and product liability law in South Africa.
The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
To read the full Q&A, visit Thomsan Reuters Practical Law.
For information on pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports, visit Pharmaceutical IP and Competition Law in South Africa: overview.
North African countries collaborate to strengthen anti-counterfeiting measures in an environmentally sustainable manner
Countries in Northern Africa, including Tunisia, Algeria, Morocco and Egypt have been increasing their focus on anti-counterfeiting and protection and enforcement of intellectual property rights. A se...
December 14 2023
Recent successes in appeals for delays in meeting formalities deadlines for patent matters in Egypt
Egypt is one of several countries that still require applicants to obtain legalisation of certain documents when filing patent, design or trademark applications in that country. Failure to file the le...
December 14 2023
47th Session of the Administrative Council and 19th Session of the Council of Ministers of the African Regional Intellectual Property Organization (ARIPO) held in Gaborone, Botswana
The 47th Session of the Administrative Council of ARIPO was held in Gaborone, Botswana from 20 – 23 November 2023. Adams & Adams Partners, Nicky Garnett and Jameel Hamid, together with the A...
December 14 2023
